Table 1.
Novel genomic alterations with prognostic or therapeutic relevance
BCP-ALL indicates B-cell precursor acute lymphoblastic leukemia; GEP, gene expression profile; CNA, copy number abnormalities; and TKI, tyrosine kinase inhibitor.
Adapted from Pui et al.1
